SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
__________________
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date
of
Report (Date of earliest event reported): April 3, 2008
|
THE
FEMALE HEALTH
COMPANY
|
|
(Exact
name of registrant as specified in its
charter)
|
|
Wisconsin
|
|
(State
or other jurisdiction of
incorporation)
|
|
1-13602
|
|
39-1144397
|
|
(Commission
File Number)
|
|
(I.R.S.
Employer I.D. Number)
|
|
515
North State Street
Suite
2225
Chicago,
Illinois
|
|
60610
|
|
(Address
of Principal Executive Offices)
|
|
(Zip
Code)
|
|
312-595-9123
|
|
(Registrant's
telephone number, including area code)
|
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see
General
Instruction A.2. below):
o
Written communications pursuant to Rule 425 under the Securities Act
(17
CFR230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR
240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))
Section
7 – Regulation FD
Item
7.01 Regulation FD Disclosure
On
April 3, 2008, The Female
Health Company issued a press release (the "Press Release") announcing an
expansion and extension of its stock repurchase program and providing financial
guidance for its fiscal year ending September 30, 2008. A copy
of the Press Release is attached as Exhibit 99.1 to this
report. The attached Exhibit 99.1 is furnished pursuant to
Item 7.01 of Form 8-K.
The
information in this Form 8-K and
the Exhibit attached hereto shall not be deemed "filed" for purposes of Section
18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated
by reference in any filing under the Securities Act of 1933 or the Securities
Exchange Act of 1934, except as shall be expressly set forth by specific
reference in such filing.
Section
9 – Financial Statements and Exhibits
Item
9.01 Financial Statements and
Exhibits
(d) Exhibits
The
following exhibit is furnished herewith:
Exhibit 99.1
–
Press
Release of
The Female Health Company, issued April 3, 2008.
SIGNATURES
Pursuant
to the requirements of the
Securities Exchange Act of 1934, the registrant has duly caused this report
to
be signed on its behalf by the undersigned hereunto duly authorized.
THE
FEMALE HEALTH COMPANY
Date: April 3,
2008
BY
/s/
Donna
Felch
Donna
Felch, Vice President
and
Chief
Financial Officer